Appendix serological criteria for calculation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Significant increases in antibody (measured by ELISA) to all vaccine serotypes were seen after administration of single doses of Prevenar to children aged 2 to 5 years.